Drugs / AMG 172
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01497821 | Jan 2012 → Nov 2014 | clear cell renal carcinoma | Amgen | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMG 172 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01497821 ↗ |